MAM
AGN

Myriad Asset Management’s Allergan plc AGN Stock Holding History

Myriad Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-53,110
Closed -$9.4M – 112
2020
Q1 		$9.4M Sell
53,110
-16,390
-24% -$3.09M 1.41% 23
2019
Q4 		$13.3M Sell
69,500
-12,000
-15% -$2.16M 1.61% 18
2019
Q3 		$13.7M Buy
81,500
+77,500
+1,938% +$12.6M 1.41% 18
2019
Q2 		$669K Buy
+4,000
New +$554K 0.06% 84

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Myriad Asset Management's AGN Position: Q2 2020 in Review

Myriad Asset Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 53,110 shares — an estimated $9.4M sold.

Myriad Asset Management first reported a position in AGN in Q2 2019 and held it in 4 quarters. The position peaked at $13.7M in Q3 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Myriad Asset Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Myriad Asset Management sold 53,110 Allergan plc shares in Q2 2020, an estimated $9.4M.
  • Myriad Asset Management first reported a position in Allergan plc in Q2 2019 and held it in 4 quarters.
  • Myriad Asset Management's Allergan plc position peaked at $13.7M in Q3 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Myriad Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.